AMHR2 and ovarian carcinoma: In contrast to evidence suggesting an origin for human ovarian cancer in the epithelium of the fallopian tube, Kim et al. identified early lesions in the stroma of the oviduct, consistent with the expression pattern from the Amhr2 promoter in this tissue[58].